Form 4 for IDXX Idexx Laboratories
Accepted 2023-05-08 00:00:00 ET · period of report 2023-05-05 · accession 0000874716-23-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | 2023-05-05 | IDXX | Lane Michael | EVP | S - Sale | $484.00 | -1,000 | 4,022 | -20% | -$484.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-05 | S | D | 1,000 | $484.00 | 4,021.99 | D | — | — | (F1) Includes 14.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023. |